Study of treatments for advanced brain and spinal cord tumors
Part of Brain & nervous system, Cancer clinical trials.
This study looks at how different treatments work for people with advanced brain or spinal cord tumors that have come back. It helps doctors learn more about these tumors and how to better treat them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have an advanced brain or spinal cord tumor that has come back or is growing, including certain types of gliomas or other recurrent CNS tumors.
- You are scheduled for a brain tumor biopsy or surgery at the NIH (National Institutes of Health).
- If you've had radiation therapy, it must have been at least 6 months ago.
- You are 15 years old or older.
- You (or your legal guardian) can understand and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an observational study that collects and compares information from patients with primary brain tumors and their treatment results. It uses stored tumor tissue and brain scans to better understand outcomes using updated tumor classification methods.
This study looks at leftover tumor cells in people with a type of brain tumor called IDH-mutant glioma. Doctors want to learn how many tumor cells remain after treatment by testing tissue from a biopsy or surgery. This may help improve future care.
This trial studies how brain tumors (like high-risk gliomas, medulloblastoma, and ependymoma) respond to treatment and why they sometimes become resistant. It is for young people aged 15 to 39 and aims to use tumor tissue samples to understand the tumor better and guide future therapies.
This study tests a new way to choose treatment for people with brain tumors that have not responded to standard therapies. Your tumor sample is analyzed in the lab to find which drugs might work best for you, and then you receive a personalized treatment plan.
This trial tests a combination of two drugs (D2C7-IT and 2141-V11) given directly into the brain after surgery for people with recurrent glioblastoma. The goal is to see if this treatment is safe and can help control the tumor.
This trial collects tumor samples to study what causes glioblastoma to return. It may help scientists find better treatments.
Hear when a new Brain Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.